Brief: Laurus Labs Approves Investment Up To EUR 9.8 Million In KRKA Pharma
30/04/2026 11:13
April 30 (Reuters) - Laurus Labs Ltd LAUL.NS: LAURUS LABS - APPROVES INVESTMENT UP TO EUR 9.8 MILLION IN KRKA PHARMA PRIVATE LIMITED LAURUS LABS - KRKA D.D. NOVO MESTO, SLOVENIA (CO-VENTURER) TO INVEST ABOUT EUR 10.2 MILLION IN KRKA PHARMA Source text: ID:nNSE58vwvh Further company coverage: LAUL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs gains after quarterly results
Brief: Laurus Labs Approves Investment Up To EUR 9.8 Million In KRKA Pharma
Brief: Laurus Labs Board Approves Voluntary Closure Of Unit In Germany
Brief: Laurus Labs March-Quarter Consol Net Profit 2.79 Billion Rupees
Brief: Laurus Labs Posts Dec-Quarter Consol Net PAT Of 2.52 Billion Rupees